Ipsen S.A. inc

106 Allen Rd Fl 3 , Basking Ridge, NJ 07920

Public
Healthcare & Pharmaceuticals - Pharmaceuticals
around $100 - 500M
around 1K - 5K
(908) 275-6300
908-275-6301


Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding .1 billion in 2011. Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology / Dysport®, endocrinology / Somatuline®, uro-oncology / Decapeptyl® and hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient-driven platforms, peptides and toxins. In 2011, R&D expenditure totaled more than 50 million, above 21% of Group sales. The Group has total worldwide staff of close to 4,500. Ipsen's shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the Serv... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Ipsen S.A. inc?


163 Contacts at this company
Ronnie Volino
Manager, Fleet & Marketing Fulfillment ...
Angela Bulawski
Director, Clinical Operations ...
Alexander Falto
Strategic Market Director
Jennifer Woods, SPHR
Human Resources Director
Chris Hawkins
Senior Director Human Resources
Kimberly Baldwin
Vice President, Franchise Head ...
George Betts, MBA, CPM
Executive Director, Medical
Jianying Shi
Business Partner, R&D IT
Angela M. Castagna
Clinical Operations Consultant ...

Sep 21, 2018 19:18:57
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that [...]

Sep 21, 2018 17:30:58
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that [...]

Jul 26, 2018 17:49:03
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a [...]

Jul 26, 2018 17:31:00
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a [...]

Jul 19, 2018 17:06:32
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Ipsen, a global [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.